- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KR-03-0068545

About Impilo Pharmaceuticals Private Limited
Data last updated:
Impilo Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2015PTC078093. Its GSTIN is 29AADCI7118K1Z9 (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Kannambadi Thammaiah Subramaniam (Managing Director) and Vijay Mathodu Eshwarappa (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Shed No. 101 1st Floor Ind Esta Rajajinagar, Bangalore, Karnataka, India – 560010.
As per the financials filed for FY 2019, the company reported a revenue of ₹51.17 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Lakh (net margin 2.9%) and EBITDA of ₹2.98 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.
Court records list 1 case involving the company, including 1 filed against it.
Impilo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0068545). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website impilopharma.in.
Company details
Recognitions & Rankings of Impilo Pharmaceuticals
Contact details
Impilo Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is impilopharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShed No. 101 1st Floor Ind Esta Rajajinagar, Bangalore, Karnataka, India – 560010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Impilo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Impilo Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Impilo Pharmaceuticals Private Limited, buy the company report.
Financials of Impilo Pharmaceuticals Private Limited
FY 2019 filings availableImpilo Pharmaceuticals Private Limited reported revenue of ₹51.17 Lakh (up 20% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 20% growth in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹51.17 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Impilo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Impilo Pharmaceuticals Private Limited
Impilo Pharmaceuticals has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya Ashish Shinge | Additional Director | 02 Aug 2016 | 10 Years 2 Months | Current |
| Vijay Mathodu Eshwarappa | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Aruna Mallippanahalli Dharmeshappa | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Kannambadi Thammaiah Subramaniam | Managing Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Pradeep Tokasandra Siddegowda | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
| Ravishankar Krishnamurthy | Whole-Time Director | 05 Jan 2015 | 11 Years 9 Months | Current |
Auditor
Impilo Pharmaceuticals Private Limited is audited by N RAVI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N RAVI & CO | FY 2019 | 006516S |
Shareholding
The shareholding of Impilo Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Impilo Pharmaceuticals Private Limited, buy the company report.
Legal cases
Impilo Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by M/S Apple Biotech | Disposed |
To see the full case history of Impilo Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Impilo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Impilo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCI7118K1Z9 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Impilo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Impilo Pharmaceuticals Private Limited has 6 board changes on record since 2015: 6 appointments. The latest: Sandhya Ashish Shinge was appointed as Additional Director on 02 Aug 2016.
Frequently asked questions
Impilo Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 2015 (11+ years old) and is registered under CIN U24232KA2015PTC078093.
Impilo Pharmaceuticals has 6 current directors:
- Kannambadi Thammaiah Subramaniam - Managing Director
- Vijay Mathodu Eshwarappa - Whole-Time Director
- Aruna Mallippanahalli Dharmeshappa - Whole-Time Director
- Pradeep Tokasandra Siddegowda - Whole-Time Director
- Ravishankar Krishnamurthy - Whole-Time Director
- Sandhya Ashish Shinge - Additional Director
The latest financial statements of Impilo Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Impilo Pharmaceuticals is 29AADCI7118K1Z9, registered in Karnataka.
The CIN (Corporate Identification Number) of Impilo Pharmaceuticals is U24232KA2015PTC078093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Impilo Pharmaceuticals has 1 court case on record: 1 filed against it.
Impilo Pharmaceuticals was incorporated on 05 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
Sandhya Ashish Shinge was appointed as Additional Director on 02 Aug 2016. Aruna Mallippanahalli Dharmeshappa was appointed as Whole-Time Director on 05 Jan 2015. Kannambadi Thammaiah Subramaniam was appointed as Managing Director on 05 Jan 2015. Impilo Pharmaceuticals has 6 board changes on record in total.
Yes, Impilo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0068545).
Impilo Pharmaceuticals can be reached through the website impilopharma.in. Its registered office is in Bangalore, Karnataka, India.